Who owns Affimed Therapeutics B V?
- CUSIP Number: n01045108
Tip: Access positions for across all investors
Analyze quarterly positions in Affimed Therapeutics B V with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Affimed Therapeutics B V stock
Who bought or sold Affimed Therapeutics B V this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ridgeback Capital Investments | 15M | $9.3M | 100% | Dec 2023 |
|
| 683 Capital Management | 7.0M | $4.4M | -15% | Dec 2023 |
|
| NEA Management Company | 4.4M | $2.8M | 0% | Dec 2023 |
|
| Point72 Asset Management | 4.2M | $2.6M | 0% | Dec 2023 |
|
| Millennium Management | 2.0M | $1.3M | -34% | Dec 2023 |
|
| Vanguard Group | 1.4M | $881k | 0% | Dec 2023 |
|
| Two Sigma Advisers | 690k | $431k | -7% | Dec 2023 |
|
| Kennedy Capital Management | 632k | $395k | 100% | Dec 2023 |
|
| Two Sigma Investments | 632k | $395k | -16% | Dec 2023 |
|
| Marshall Wace | 607k | $383k | 100% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 572k | $358k | 40% | Dec 2023 |
|
| Intellectus Partners | 410k | $257k | 3% | Dec 2023 |
|
| Alyeska Investment Group | 350k | $219k | 0% | Dec 2023 |
|
| Standard Life Aberdeen | 209k | $130k | 100% | Dec 2023 |
|
| Commonwealth Equity Services | 205k | $128k | 264% | Dec 2023 |
|
| Ewa | 143k | $78k | 100% | Dec 2023 |
|
| Wells Fargo & Company | 140k | $87k | -14% | Dec 2023 |
|
| Two Sigma Securities | 84k | $52k | 6% | Dec 2023 |
|
| Squarepoint Ops | 80k | $50k | 336% | Dec 2023 |
|
| Barclays | 75k | $48k | 0% | Dec 2023 |
|
| Citadel Advisors | 75k | $47k | 17% | Dec 2023 |
|
| Jane Street | 57k | $36k | -56% | Dec 2023 |
|
| LMR Partners | 51k | $32k | 0% | Dec 2023 |
|
| Advisor Group Holdings | 42k | $26k | -19% | Dec 2023 |
|
| Cubist Systematic Strategies | 40k | $25k | -51% | Dec 2023 |
|
| Royal Bank of Canada | 38k | $0 | -12% | Dec 2023 |
|
| Goldman Sachs Group | 27k | $17k | -51% | Dec 2023 |
|
| Us Bancorp | 24k | $15k | 0% | Dec 2023 |
|
| Clear Harbor Asset Management | 15k | $8.2k | 0% | Dec 2023 |
|
| Bank Of Montreal | 14k | $8.5k | -7% | Dec 2023 |
|
| Dimensional Fund Advisors | 13k | $8.3k | -88% | Dec 2023 |
|
| HighTower Advisors | 11k | $7.0k | 100% | Dec 2023 |
|
| A. Montag and Associates | 10k | $6.3k | 100% | Dec 2023 |
|
| Pnc Financial Services | 6.0k | $3.8k | 0% | Dec 2023 |
|
| Point72 Asia | 4.2k | $2.6k | 100% | Dec 2023 |
|
| Bank of America Corporation | 1.8k | $902.000000 | -60% | Dec 2023 |
|
| Newbridge Financial Services Group | 1.5k | $937.050000 | 0% | Dec 2023 |
|
| IFP Advisors | 1.2k | $718.980000 | 0% | Dec 2023 |
|
| Simplex Trading | 900.00 | $0 | -23% | Dec 2023 |
|
| Ronald Blue Trust | 335.00 | $0 | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 199.00 | $123.996900 | -99% | Dec 2023 |
|
| Parkside Financial Bank & Trust | 150.00 | $94.005000 | 100% | Dec 2023 |
|
| Citigroup | 122.00 | $77.640800 | -94% | Dec 2023 |
|
| Cape Investment Advisory | 100.00 | $63.000000 | 0% | Dec 2023 |
|
Who sold out of Affimed Therapeutics B V?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Baker Bros. Advisors | Sep 2023 | 4.4M | $2.1M |
| VR Adviser | Sep 2023 | 1.4M | $683k |
| Brown Advisory Holdings Incorporated | Dec 2023 | 90k | $56k |
| Harbor Investment Advisory | Dec 2023 | 59k | $37k |
| Balyasny Asset Management | Sep 2023 | 10k | $4.8k |
| China Universal Asset Management | Sep 2023 | 3.8k | $2.0k |
| Wetzel Investment Advisors | Dec 2023 | 1.0k | $1.0k |
| Daiwa Securities Group | Sep 2023 | 407.00 | $0 |